FIND A PROTON CENTER
National Association for Proton Therapy National Association for Proton Therapy National Association for Proton Therapy National Association for Proton Therapy
  • ABOUT
    • About NAPT
      • Leadership
      • NAPT Foundation
      • Corporate Partners
    • Our Advocacy
    • Patient Advocate Community
    • Awards
    • Join NAPT
  • FOR PATIENTS
    • Find A Proton Center
    • Pediatric Proton Therapy
    • Resource Center
    • FAQ
    • Patient Stories
    • Clinical Trials
  • FOR PROVIDERS
    • Clinical Research
    • Clinical Trials
  • EVENTS
  • NEWS
  • Member Log-in
National Association for Proton Therapy National Association for Proton Therapy
  • ABOUT
    • About NAPT
      • Leadership
      • NAPT Foundation
      • Corporate Partners
    • Our Advocacy
    • Patient Advocate Community
    • Awards
    • Join NAPT
  • FOR PATIENTS
    • Find A Proton Center
    • Pediatric Proton Therapy
    • Resource Center
    • FAQ
    • Patient Stories
    • Clinical Trials
  • FOR PROVIDERS
    • Clinical Research
    • Clinical Trials
  • EVENTS
  • NEWS
  • Member Log-in
Feb 14

A Third of Docs Saw a Patient Harmed by Prior Authorization

  • February 14, 2022

One-third of the 1,001 physicians surveyed (PDF) by the AMA in December reported that prior authorization has led to a serious adverse event for a patient in their care.

More specifically, the AMA survey found that these shares of the physician respondents reported that prior authorization led to:

  • A patient’s hospitalization—25%.
  • A life-threatening event or one that required intervention to prevent permanent impairment or damage—19%.
  • A patient’s disability or permanent bodily damage, congenital anomaly or birth defect, or death—9%.

“Health plans continue to inappropriately impose bureaucratic prior authorization policies that conflict with evidence-based clinical practices, waste vital resources, jeopardize quality care, and harm patients,” said AMA President Jack Resneck Jr., MD. “The byzantine system of authorization controls is rife with opportunities for reform, and the AMA continues to work with federal and state officials on legislative solutions to reduce waste, improve efficiency, and protect patients from obstacles to medically necessary care.”

According to the AMA survey, 86% of physicians reported that prior authorization requirements led to greater use of health care resources, resulting in unnecessary waste instead of cost savings. More specifically, about two-thirds of physicians reported resources were diverted to ineffective initial treatments (64%) or additional office visits (62%) due to prior-authorization policies, while 46% of physicians reported prior-authorization policies led to urgent or emergency care for patients.

  • Facebook
  • Twitter
  • Reddit
  • Pinterest
  • Google+
  • LinkedIn
  • E-Mail

Related Posts

NEWS BY TOPIC

The Latest Proton News

  • Benny’s Story: A Brain Tumor Awareness Month Spotlight
  • 2025 National Proton Conference Highlights Major Advances in Research, Patient Access, and Clinical Innovation
  • Coach Goes Head-to-Head with Cancer
  • Mark Kahrs: Moving Forward After Head and Neck Cancer
  • Advancing Cancer Care: Landmark Study Underscores Proton Therapy’s Impact in Head and Neck Cancer

The National Association for Proton Therapy (NAPT) and its members support cancer research and treatment innovation and are committed to raising awareness about the value of proton therapy among policymakers, insurers, caregivers and patients to ensure that this advanced treatment modality is affordable and available in communities across the country.

  • Connected Community Log In
  • Privacy Policy
  • Terms of Use

LATEST NAPT NEWS

  • Benny’s Story: A Brain Tumor Awareness Month Spotlight
  • 2025 National Proton Conference Highlights Major Advances in Research, Patient Access, and Clinical Innovation
  • Coach Goes Head-to-Head with Cancer
  • Mark Kahrs: Moving Forward After Head and Neck Cancer
  • Advancing Cancer Care: Landmark Study Underscores Proton Therapy’s Impact in Head and Neck Cancer

CONTACT US

The National Association for Proton Therapy 
202.919.5554

© 2025 National Association for Proton Therapy (NAPT)